NVDA

186.56

-0.61%↓

AVGO.US

346.17

-1.07%↓

ORCL

194.87

-1.14%↓

MU

285.63

-2.39%↓

CSCO

77

-0.54%↓

NVDA

186.56

-0.61%↓

AVGO.US

346.17

-1.07%↓

ORCL

194.87

-1.14%↓

MU

285.63

-2.39%↓

CSCO

77

-0.54%↓

NVDA

186.56

-0.61%↓

AVGO.US

346.17

-1.07%↓

ORCL

194.87

-1.14%↓

MU

285.63

-2.39%↓

CSCO

77

-0.54%↓

NVDA

186.56

-0.61%↓

AVGO.US

346.17

-1.07%↓

ORCL

194.87

-1.14%↓

MU

285.63

-2.39%↓

CSCO

77

-0.54%↓

NVDA

186.56

-0.61%↓

AVGO.US

346.17

-1.07%↓

ORCL

194.87

-1.14%↓

MU

285.63

-2.39%↓

CSCO

77

-0.54%↓

Search

Azenta Inc

Fechado

SetorTecnologia

33.22 -1.86

Visão Geral

Variação de preço das ações

24h

Atual

Mín

32.99

Máximo

33.9

Indicadores-chave

By Trading Economics

Rendimento

50M

51M

Vendas

15M

159M

P/E

Médio do Setor

65.434

56.104

Margem de lucro

31.944

Funcionários

3,000

EBITDA

2.7M

21M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+10.52% upside

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

249M

1.6B

Abertura anterior

35.08

Fecho anterior

33.22

Sentimento de Notícias

By Acuity

50%

50%

140 / 403 Ranking em Technology

Azenta Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

31 de dez. de 2025, 22:20 UTC

Grandes Movimentos do Mercado

Outlook Therapeutics Shares Fall After Another FDA Rejection of Macular Degeneration Drug

31 de dez. de 2025, 17:31 UTC

Grandes Movimentos do Mercado

OwlTing Climbs on Launch of $10 Million Stock-Buyback Program

31 de dez. de 2025, 16:30 UTC

Grandes Movimentos do Mercado

Trump Media Gains on Plan to Distribute Digital Tokens to Shareholders

31 de dez. de 2025, 15:19 UTC

Grandes Movimentos do Mercado

Axsome Shares Climb on FDA Fast‑Track for Alzheimer's Drug, Backing for Narcolepsy Filing

31 de dez. de 2025, 15:17 UTC

Grandes Movimentos do Mercado

Nike Shares Rise After CEO Hill Buys $1 Million of Shares

31 de dez. de 2025, 14:37 UTC

Grandes Movimentos do Mercado

Corcept Shares Fall as FDA Requires More Evidence for Hypercortisolism Drug Application

31 de dez. de 2025, 21:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

31 de dez. de 2025, 21:13 UTC

Aquisições, Fusões, Aquisições de Empresas

10 People to Watch in Wealth Management in 2026 -- Barrons.com

31 de dez. de 2025, 20:40 UTC

Conversa de Mercado

Dollar Posting Its Worst Year Since 2017 -- Market Talk

31 de dez. de 2025, 20:22 UTC

Conversa de Mercado

Oil Posts Loss in a Year Marked By Plentiful Supply -- Market Talk

31 de dez. de 2025, 19:50 UTC

Conversa de Mercado

U.S. Natural Gas Futures Sink on Weather Outlook -- Market Talk

31 de dez. de 2025, 19:31 UTC

Conversa de Mercado

Precious Metals Cap Off Record Runs -- Market Talk

31 de dez. de 2025, 18:50 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

31 de dez. de 2025, 18:50 UTC

Conversa de Mercado

Canadian Gold Miners Enjoy a Bumper Year in 2025 -- Market Talk

31 de dez. de 2025, 17:17 UTC

Conversa de Mercado

U.S. Natural Gas Inventories Fall Less Than Expected -- Market Talk

31 de dez. de 2025, 17:16 UTC

Grandes Movimentos do Mercado

OwlTing Climbs on Launch of $10M Stock-Buyback Program

31 de dez. de 2025, 17:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

31 de dez. de 2025, 17:00 UTC

Aquisições, Fusões, Aquisições de Empresas

Nvidia Is Getting Creative as Options to Use Its Cash Flood Narrow -- Heard on the Street -- WSJ

31 de dez. de 2025, 15:57 UTC

Aquisições, Fusões, Aquisições de Empresas

Vanda Pharmaceuticals Shares Jump 30% on Motion Sickness Drug Approval -- Barrons.com

31 de dez. de 2025, 15:54 UTC

Conversa de Mercado

Layoff Data Supports Dollar at End of Losing Year -- Market Talk

31 de dez. de 2025, 15:02 UTC

Grandes Movimentos do Mercado

Nike Shares Rise After CEO Hill Buys $1M of Shares

31 de dez. de 2025, 14:40 UTC

Aquisições, Fusões, Aquisições de Empresas

Nike CEO Buys $1 Million of Stock as Insiders Bet on a Turnaround -- Barrons.com

31 de dez. de 2025, 14:20 UTC

Conversa de Mercado

Crude Futures On Track to End the Year With Losses -- Market Talk

31 de dez. de 2025, 13:46 UTC

Conversa de Mercado

U.S. Natural Gas Falls on Milder Weather Outlook -- Market Talk

31 de dez. de 2025, 13:01 UTC

Ganhos
Aquisições, Fusões, Aquisições de Empresas

Charles Schwab Is Back on Offense. Its Stock Is a Buy. -- Barrons.com

31 de dez. de 2025, 11:10 UTC

Conversa de Mercado

Copper Remains in Touching Distance of Record Highs -- Market Talk

31 de dez. de 2025, 10:46 UTC

Conversa de Mercado

Euro on Track For Strong Annual Performance -- Market Talk

31 de dez. de 2025, 10:25 UTC

Conversa de Mercado

European Gas Prices Rise But Remain on Track for Heavy Annual Loss -- Market Talk

31 de dez. de 2025, 10:23 UTC

Conversa de Mercado

Chinese Yuan Rises to 31-Month High Against Dollar as Policymakers -- Market Talk

31 de dez. de 2025, 09:33 UTC

Conversa de Mercado

Dollar Set For Worst Annual Performance Since 2017 -- Market Talk

Comparação entre Pares

Variação de preço

Azenta Inc Previsão

Preço-alvo

By TipRanks

10.52% parte superior

Previsão para 12 meses

Média 38.33 USD  10.52%

Máximo 45 USD

Mínimo 31 USD

Com base em 6 analistas de Wall Street que oferecem metas de preço de 12 meses para Azenta Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

6 ratings

3

Comprar

3

Manter

0

Vender

Sentimento

By Acuity

140 / 403 Ranking em Tecnologia

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Azenta Inc

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in the United States, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates through three reportable segments: Sample Management Solutions, Multiomics, and B Medical Systems. The Sample Management Solutions segment provides sample management products and solutions, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services. This segment also offers consultation services to clients throughout their experimental design and implementation processes. The Multiomics segment provides genomic and other sample analysis services comprising gene sequencing, synthesis editing, and related services. The B Medical Systems segment manufactures and distributes temperature-controlled storage and transportation solutions to governments, health institutions, and non-government organizations. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.
help-icon Live chat